Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.58 |
| ▸ | RAB9A | P51151 | 8/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9435490 | 0.86 | SMN1; SMN2 (0.57) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL423622 | 0.86 | SMN1; SMN2 (0.57) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL7049219 | 0.84 | SMN1; SMN2 (0.53) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL11334284 | 0.82 | SMN1; SMN2 (0.51) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL11334531 | 0.79 | — | — | |
| SCHEMBL4325251 | 0.79 | ALDH1A1 (0.58) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL10897831 | 0.78 | HPGD (0.39) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL25239244 | 0.78 | HASPIN (0.46) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| SCHEMBL18413073 | 0.78 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2MAPK1MAPT | |
| Triphenyl Phosphate SCHEMBL29199645 | 0.77 | RAB9A (0.50) | NPC1RAB9ASMN1; SMN2MAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118125983-A | Synthesis method of ticagrelor intermediate | 南京一心和医药科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-116685300-A | Composition comprising one or more (bio) -alkanediols with an antioxidant | 西姆莱斯股份公司 | 2023-09-01 | — | — | CN | claimed |
| EP-2655341-A2 | NOVEL PROCESSES FOR PREPARING TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | Actavis Group Ptc Ehf (IS) | 2013-10-30 | — | — | EP | claimed |
| WO-2012085665-A2 | NOVEL PROCESSES FOR PREPARING TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF | ACTAVIS GROUP PATC EHF (IS) | 2012-06-28 | — | — | WO | claimed |
| CN-119744164-A | Odor and colorant stable compositions | 西姆莱斯股份公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-118870978-A | Stable agrochemical composition | UPL有限责任公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118829355-A | Method for controlling resistant and non-resistant pests | UPL有限责任公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118829416-A | Composition (III) | 西姆莱斯股份公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118141701-A | Composition containing benzoic acid derivative or furoic acid derivative and use of the derivative for emulsion and foam stability | 西姆莱斯股份公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118125983-A | Synthesis method of ticagrelor intermediate | 南京一心和医药科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118125983-A | Synthesis method of ticagrelor intermediate | 南京一心和医药科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117915774-A | Novel insecticidal compositions comprising elemental sulfur and Acynonapyr | 希特逊库玛·阿尼凯特·多希 | 2024-04-19 | — | — | CN | disclosed |
| CN-103749824-A | Gynostemma pentaphyllum health-care tea capable of lowering blood sugar and blood pressure and preparation method thereof | QINGDAO HENGBO INSTR CO LTD | 2014-04-30 | — | — | CN | disclosed |
| CN-103734425-A | Health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid and preparation method of tea | QINGDAO HENGBO INSTR CO LTD | 2014-04-23 | — | — | CN | disclosed |
| US-8541402-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-09-24 | — | — | US | disclosed |
| US-8476257-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-07-02 | — | — | US | disclosed |
| EP-2030971-B1 | PEST CONTROL AGENT CONTAINING NOVEL PYRIDYL-METHANAMINE DERIVATIVE OR SALT THEREOF | ISHIHARA SANGYO KAISHA (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20100160326-A1 | PEST CONTROL AGENT CONTAINING NOVEL PYRIDYL-METHANAMINE DERIVATIVE OR SALT THEREOF | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160326-A1 | PEST CONTROL AGENT CONTAINING NOVEL PYRIDYL-METHANAMINE DERIVATIVE OR SALT THEREOF | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| WO-2009018657-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160326-A1 | PEST CONTROL AGENT CONTAINING NOVEL PYRIDYL-METHANAMINE DERIVATIVE OR SALT THEREOF | HCN1, HCN3, HCN2 | NPC1 1513/4885RAB9A 1005/4885SMN1; SMN2 2794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.